Hostname: page-component-7b7567c8c-2rsb6 Total loading time: 0 Render date: 2026-11-12T08:22:05.282Z Has data issue: false hasContentIssue false
  • English
  • Français

Explanatory and pragmatic trials

Published online by Cambridge University Press:  18 May 2011

Corrado Barbui,
Antonio Veronese and
Andrea Cipriani
Corrado Barbui*
Affiliation:
Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona
Antonio Veronese
Affiliation:
Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona
Andrea Cipriani
Affiliation:
Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona
*
Address for correspondence: Dr. C. Barbui, Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L.A. Scuro, 10 - 37134 Verona, Italy. Fax: +39-045-585.871 E-mail: corrado.barbui@univr.it
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

explanatory trialspragmatic trialsefficacyeffectiveness.

Information

Type
ABC of Methodology
Information
Epidemiology and Psychiatric Sciences , Volume 16 , Issue 2 , June 2007, pp. 124 - 125
Copyright
Copyright © Cambridge University Press 2007

References

Geddes, J.R. (2005). Large simple trials in psychiatry: providing reliable answers to important clinical questions. Epidemiologia e Psichiatria Sociale 14, 122–126.CrossRefGoogle ScholarPubMed
Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) (1986). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1, 397–402.Google Scholar
Jones, P.B., Barnes, T.R., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K.P., Murray, R.M., Markwick, A. & Lewis, S.W. (2006). Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Archives of General Psychiatry 63, 1079–1087.CrossRefGoogle Scholar
Lieberman, J.A., Stroup, T.S., McEvoy, J.P., Swartz, M.S., Rosenheck, R.A., Perkins, D.O., Keefe, R.S., Davis, S.M., Davis, C.E., Lebowitz, B.D., Severe, J. & Hsiao, J.K. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353, 1209–1223.CrossRefGoogle ScholarPubMed
March, J.S., Silva, S.G., Compton, S., Shapiro, M., Califf, R. & Krishnan, R. (2005). The case for practical clinical trials in psychiatry. American Journal of Psychiatry 162, 836–846.CrossRefGoogle ScholarPubMed
Schwartz, D. & Lellouch, J. (1967). Explanatory and pragmatic attitudes in therapeutical trials. Journal of Chronic Diseases 20, 637–648.CrossRefGoogle ScholarPubMed
Stroup, S. (2005). Practical clinical trials for schizophrenia. Epidemiologiae Psichiatria Sociale 14, 132–136.CrossRefGoogle ScholarPubMed
Tognoni, G. & Franzosi, M.G. (2005). [Experimenting in Italy: from GISSI to the Ministerial Decree]. Recenti Progressi in Medicina 96, 92–94.Google Scholar